Samsung Biologics plans to allocate KRW2.71T for PolyPeptide acquisition
Plans to allocate about KRW2.71T of offering proceeds to buy PolyPeptide Group and KRW290B for expansion of Bio Campus II.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.